Close Menu
July 25, 2019

The Case for a Universal FLT3 Assay

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This on-demand webinar from Invivoscribe describes the advantages of using a highly validated and precise companion diagnostic in the assessment of FLT3 mutations in AML patients.